Group 1 - The core viewpoint of the article highlights Tianyi Medical's stock performance, with a closing price of 58.97 yuan on November 27, reflecting a 1.71% increase and a rolling PE ratio of 267.24 times, with a total market capitalization of 3.476 billion yuan [1] - The average PE ratio for the medical device industry is 51.68 times, with a median of 40.10 times, positioning Tianyi Medical at the 119th rank within the industry [1] - On November 27, Tianyi Medical experienced a net inflow of 1.8354 million yuan in main funds, although it has seen a total outflow of 13.52 million yuan over the past five days [1] Group 2 - Tianyi Medical specializes in the research, production, and sales of medical devices in the fields of blood purification and ward care, with key products including extracorporeal circulation blood lines and disposable medical supplies [1] - The latest financial results for the third quarter of 2025 show that the company achieved an operating income of 387 million yuan, a year-on-year increase of 24.14%, and a net profit of 20.0941 million yuan, reflecting a significant year-on-year increase of 216.81%, with a sales gross margin of 38.39% [1]
天益医疗收盘上涨1.71%，滚动市盈率267.24倍，总市值34.76亿元